We are live on ! Find out more
GIM

Groesbeck Investment Management Portfolio holdings

AUM $62.8M
1-Year Est. Return 52.32%
This Fund
S&P 500
This Quarter Est. Return
+8.49%
1 Year Est. Return
+52.32%
3 Year Est. Return
+146.85%
5 Year Est. Return
+188.49%
10 Year Est. Return
+524.09%
AUM
$241M
AUM Growth
+$9.85M
Cap. Flow
-$6.24M
Cap. Flow %
-2.59%
Top 10 Hldgs %
30.99%
Holding
85
New
13
Increased
9
Reduced
43
Closed
4

Top Buys

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$5.36M
2
CVI icon
CVR Energy
CVI
+$3.29M
3
V icon
Visa
V
+$2.67M
4
GNC
GNC Holdings, Inc.
GNC
+$2.48M
5
NUS icon
Nu Skin
NUS
+$2.28M

Sector Composition

Rank Sector Weight
1 Technology 16.16%
2 Healthcare 14.63%
3 Consumer Discretionary 13.04%
4 Energy 12.29%
5 Consumer Staples 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$8.48M 3.52%
423,052
+7,644
+2% +$144K
TUP
2
DELISTED
Tupperware Brands Corporation
TUP
$8.4M 3.49%
88,866
-13,498
-13% -$1.23M
ABBV icon
3
AbbVie
ABBV
$455B
$7.76M 3.22%
146,900
-4,639
-3% -$228K
QCOM icon
4
Qualcomm
QCOM
$160B
$7.71M 3.21%
103,892
-3,234
-3% -$228K
PX
5
DELISTED
Praxair Inc
PX
$7.38M 3.07%
56,749
-2,046
-3% -$255K
CVX icon
6
Chevron
CVX
$383B
$7.25M 3.01%
58,051
-1,889
-3% -$228K
MCD icon
7
McDonald's
MCD
$191B
$7.05M 2.93%
72,673
-12,688
-15% -$1.22M
IBM icon
8
IBM
IBM
$209B
$6.93M 2.88%
38,671
-1,943
-5% -$335K
BLK icon
9
Blackrock
BLK
$170B
$6.87M 2.86%
21,716
-976
-4% -$291K
HPQ icon
10
HP
HPQ
$24.6B
$6.72M 2.79%
529,031
UNH icon
11
UnitedHealth
UNH
$383B
$6.34M 2.64%
84,232
-3,374
-4% -$242K
VTR icon
12
Ventas
VTR
$44.7B
$6.08M 2.53%
92,909
-5,132
-5% -$356K
VFC icon
13
VF Corp
VFC
$5.87B
$6.06M 2.52%
103,227
-11,941
-10% -$622K
NUS icon
14
Nu Skin
NUS
$254M
$5.93M 2.47%
42,920
+19,370
+82% +$2.28M
BKE icon
15
Buckle
BKE
$2.27B
$5.92M 2.46%
115,344
-6,370
-5% -$315K
DLR icon
16
Digital Realty Trust
DLR
$71.5B
$5.63M 2.34%
114,686
-5,720
-5% -$284K
KMP
17
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$5.12M 2.13%
63,505
-10,900
-15% -$879K
TPR icon
18
Tapestry
TPR
$30.8B
$4.98M 2.07%
88,733
-4,187
-5% -$226K
KDP icon
19
Keurig Dr Pepper
KDP
$43B
$4.96M 2.06%
101,800
QCOR
20
DELISTED
QUESTCOR PHARMA INC
QCOR
$4.94M 2.05%
+90,774
New +$5.36M
EPB
21
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
$4.76M 1.98%
132,300
-4,883
-4% -$192K
LHX icon
22
L3Harris
LHX
$50.7B
$4.68M 1.94%
67,000
-13,500
-17% -$855K
TROW icon
23
T. Rowe Price
TROW
$25.6B
$4.5M 1.87%
53,735
-2,912
-5% -$228K
ABT icon
24
Abbott
ABT
$183B
$4.19M 1.74%
109,260
-4,159
-4% -$153K
WMT icon
25
Walmart Inc
WMT
$884B
$4.18M 1.74%
159,189
-40,842
-20% -$1.05M

Similar funds

Groesbeck Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Groesbeck Investment Management held 85 positions worth $241M, up 4.3% from $231M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Groesbeck Investment Management's Q4 2013 filing shows 13 new, 9 increased, 43 reduced and 4 closed positions. Its largest new stake was QUESTCOR PHARMA INC: 90,774 shares worth $4.94M. The largest sale was Enterprise Products Partners, an estimated $3.32M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Groesbeck Investment Management's largest Q4 2013 buy was QUESTCOR PHARMA INC: 90,774 shares worth $4.94M.
  • Groesbeck Investment Management added most to GNC Holdings, Inc. in Q4 2013, an estimated $2.48M increase.
  • Groesbeck Investment Management's biggest Q4 2013 reduction was Enterprise Products Partners, cutting an estimated $3.32M.
  • Groesbeck Investment Management fully exited L3 Technologies, Inc. in Q4 2013, selling an estimated $2.55M.
  • Groesbeck Investment Management's ten largest holdings make up 31% of its $241M portfolio in Q4 2013.
  • Groesbeck Investment Management opened 13 new positions and closed 4 in Q4 2013.
  • Groesbeck Investment Management's portfolio value rose 4.3% quarter-over-quarter to $241M.

Based on Groesbeck Investment Management's 13F filing for Q4 2013, filed 11 Feb 2014.